Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Publication

Publications

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Title
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Type
Article in International Scientific Journal
Year
2022
Authors
Figueiredo, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Costa, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maurício, MJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Figueira, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ramos, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
ISSN: 1173-2563
Publisher: Springer Nature
Indexing
Other information
Authenticus ID: P-00X-PAP
Resumo (PT):
Abstract (EN): Prostate carcinoma is a highly prevalent biologically and clinically diverse disease, generally associated with a consistent elevation of prostate-specific antigen levels. Castration-resistant prostate cancer represents a heterogeneous clinical setting that ranges from patients with an asymptomatic prostate-specific antigen elevation after hormone blockade failure and good performance status to patients with significant debilitating symptoms and rapidly progressive disease, leading to death. Nonmetastatic castration-resistant prostate cancer is a transient disease stage defined over specific criteria established within a sensitive time period. The majority of the patients with nonmetastatic castration-resistant prostate cancer will eventually develop metastatic lesions, associated with prostate cancer-specific morbidity and mortality. However, progression to metastatic disease is a heterogeneous process still not fully understood, with studies suggesting that younger age, high Gleason score (> 7), high prostate-specific antigen levels, reduced prostate-specific antigen doubling time (< 6 months), and a rapid alkaline phosphatase rise as potentially associated factors. Although the nonmetastatic castration-resistant prostate cancer treatment landscape has substantially evolved in recent years, the disease heterogeneity makes treatment decisions for this population challenging in the effort to achieve a balance between the risk of disease progression and the toxicity of new treatments in patients who often have associated comorbidities, yet are generally asymptomatic. The present article addresses the current main challenges in nonmetastatic castration-resistant prostate cancer management, including in diagnosis, owing to the development of new imaging modalities with a direct impact in disease detection, prognostic classification, as a result of the traditionally oversimplified definition of disease aggressiveness (mainly based on prostate-specific antigen doubling time), and patient selection for the most adequate treatment.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 12
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis (2024)
Another Publication in an International Scientific Journal
Freitas, E; Paiva Lopes, MJ; Cruz, MJ; Sousa, D; Valente, AC; Duarte, B; Teixeira, L; Rosas, G; Caetano, M; Mota, A; Filipe, P; Torres, T
Relative bioavailability of two enteric-coated formulations of omeprazole following repeated doses in healthy volunteers (2001)
Article in International Scientific Journal
Vaz Da Silva, M; Hainzl, D; Almeida, L; Dolgner, A; Silveira, P; Maia, J; soares-da-silva, p
Psychomotor effects of mexazolam vs placebo in healthy volunteers (2002)
Article in International Scientific Journal
Silveira, P; Vaz Da Silva, M; Dolgner, A; Almeida, L
One year of lamivudine therapy for Portuguese patients with chronic hepatitis B (2003)
Article in International Scientific Journal
Areias, J; Calinas, F; Porto, A; Carvalho, A; Freitas, D; Macedo G; Noronha, R; Cotter, J; Melico Silvestre, A; Peixe, R; Pratas, J; Barrote, D; Teixeira, R; Augusto, F; Carrilho, I; Campante, F; Velosa, J; Carvalho, L; Duarte, MA; Guerreiro, H...(mais 23 authors)
Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder (2001)
Article in International Scientific Journal
Vaz-Serra, A; Figueira, ML; Bessa-Peixoto, A; Firmino, H; Albuquerque, R; Paz, C; Dolgner, A; Vaz Da Silva, M; Almeida, L

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-13 at 05:58:06 | Privacy Policy | Personal Data Protection Policy | Whistleblowing